ÂÜÀòÂÒÂ×

Dr. Raymond Terryn’s patent producing Ph.D. work in Computational Chemistry provided him with a strong background in structuring data for drug development. Since 2014, he has applied chemical, biological, and genetic data to drug development in multiple areas: data analysis and prediction, data integration, data architecture, ETL development, and database design. He has previously developed large scale data integration, validation, and warehousing solutions for the National Institutes of Health BD2K-LINCS program. His deep and broad knowledge of drug development related data has proved invaluable in leading the development of Genetic Networks’ data infrastructure.